A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Clinical trial NCT06440005 · RECRUITING

Trial details

NCT number: NCT06440005
Sponsor: Angiex, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Advanced Cancer Locally Advanced Carcinoma Metastatic Solid Tumor Breast Cancer Prostate Cancer Colorectal Cancer Pancreatic Cancer Liver Cancer Angiosarcoma Solid Tumor

Start date: 2024-07-22
Primary completion: 2026-09-06
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.